ABT logo

ABT Abbott Laboratories

New York Stock Exchange · Medical - Devices · Healthcare

$97.50
+0.81 (+0.84%)

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceut…

Market Cap: $168.71Bwww.abbott.com

Price

$97.50+3.28%
$88.96$98.20$107.43$116.67
Jul 9Oct 2

Social Signal Score

53
5d
49
4 mentions
+0.8%
30d
53
35 mentions
-10.0%
60d
54
89 mentions
-9.6%
90d
54
89 mentions
+2.4%
news: 41 · rss: 33 · marketaux: 12 · 4chan: 1 · podcast: 2

Analyst Ratings

42 analysts
Buyconsensus
Strong Buy 0Buy 33Hold 9Sell 0Strong Sell 0
Avg price target$122+25.1%
Low $92Median $121High $143
Current Consensus

52-week range

$82.56$134.59
Last close
$97.50
Off 52w high
-27.6%
200-day average
$104.01
vs 200-day
-6.3%

Compare with other stocks off their highs

Revenue

$12.59B+137.51%
$5.30B$7.73B$10.16B$12.59B
Sep 2016Jun 2026

Analyst Estimates

FY2025
$5.15
$5.14–$5.16
19 analysts
FY2026
$5.52+7% YoY
$5.48–$5.57
18 analysts
FY2027
$6.07+10% YoY
$6.01–$6.19
18 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Robert Ford
Sector
Healthcare
Industry
Medical - Devices
Employees
115,000
Beta
0.59
Country
US
Piotroski score
5 / 9 (Middling)
Altman Z-score
3.14
www.abbott.com